67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 221 / Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05228574 (ClinicalTrials.gov)	March 11, 2022	12/1/2022	Treatment of Vascular Stiffness in ADPKD	Treatment of Vascular Stiffness in Patients With Autosomal Dominant Polycystic Kidney Disease	Autosomal Dominant Polycystic Kidney	Dietary Supplement: Sodium chloride (NaCl);Dietary Supplement: Placebo;Drug: Amiloride Hcl 5mg Tab	Erasmus Medical Center	NULL	Recruiting	18 Years	N/A	All	54	Phase 4	Netherlands
2	EUCTR2020-000433-40-NL (EUCTR)	30/12/2021	03/08/2021	Treatment of stiffness in blood vessels in patients with familial cystic kidney disease	Treatment of vascular stiffness in patients with autosomal dominant polycystic kidney disease - TRAMPOLINE	Autosomal dominant polycystic kidney disease;Therapeutic area: Not possible to specify	Trade Name: Amiloride Product Name: Amiloride INN or Proposed INN: AMILORIDE Trade Name: Sodium Chloride INN or Proposed INN: Sodium chloride Other descriptive name: Sodium Chloride	Erasmus University Medical Centre Rotterdam	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	54	Phase 4	Netherlands